Scientific Publications

Legend Biotech sponsors research with academic institutions to evaluate our agents. The manuscripts from this research are presented below.

Year :

Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort

Masaki Ri, Kenshi Suzuki, Tadao Ishida, Junya Kuroda, Taku Tsukamoto, Takanori Teshima, Hideki Goto, Carolyn C. Jackson, Huabin Sun, Lida Pacaud, Ei Fujikawa, Tzu-Min Yeh, Tomoyoshi Hatayama, Kensuke Aida, Yoshihiro Sunagawa, Shinsuke Iida

Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study

Thomas Martin, Yi Lin, Mounzer Agha, Adam D Cohen, Myo Htut, A Keith Stewart, Parameswaran Hari, Jesus G Berdeja, Saad Z Usmani, Tzu-Min Yeh, Yunsi Olyslager, Jenna D Goldberg, Jordan M Schecter, Deepu Madduri, Carolyn C Jackson, William Deraedt, Katharine S Gries, John M Fastenau, Jeremiah J Trudeau, Muhammad Akram, Lida Pacaud, Andrzej Jakubowiak, Sundar […]

Population-based cellular kinetic characterization of ciltacabtagene autoleucel in subjects with relapsed or refractory multiple myeloma

Liviawati S. Wu, Yaming Su, Claire Li, Wangda Zhou, Carolyn C. Jackson, Yu-Nien Sun, Honghui Zhou

Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access

J Mikhael, J Fowler, N Shah

Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma

Thomas Martin, Carolyn C. Jackson, Lida Pacaud, Deepu Madduri, Sundar Jagannath